查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1361548

瘧疾診斷市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按技術、最終用戶、地區和競爭細分

Malaria Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Technology, By End User, By Region and By Competition
出版日期: | 出版商: TechSci Research | 英文 73 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

預計全球瘧疾診斷市場將在 2024-2028 年預測期內快速成長。這歸因於政府資金的增加、研發活動（R&D）的增加以及世界各地瘧疾患者數量的增加。瘧疾是一種由瘧原蟲引起的危及生命的疾病，透過受感染的雌性瘧蚊叮咬傳播給人類。這是一個重大的公共衛生問題，特別是在熱帶和亞熱帶地區，這些地區的條件有利於蚊子繁殖和瘧疾傳播。瘧疾診斷市場發揮著至關重要的作用，因為它確保了瘧疾的早期和準確診斷。此外，瘧疾診斷有助於確保患者接受適當的治療，防止藥物過度使用，提供重要的疾病監測資料，並減少瘧疾的傳播。

此外，全球瘧疾診斷市場是由世界許多地區瘧疾的高盛行率推動的，特別是在撒哈拉以南非洲，瘧疾是那裡的一個主要公共衛生問題。根據世界衛生組織 (WHO) 統計，2021 年全球報告的瘧疾病例約為 2.47 億例，其中估計有 619,000 人因瘧疾死亡。世衛組織非洲區域承擔全球瘧疾負擔的巨大負擔。 2021 年，該區域出現了 95% 的瘧疾病例和 96% 的瘧疾死亡人數。

  • 全球瘧疾診斷市場（按技術）：

分子診斷測試

快速診斷測試

其他

  • 全球瘧疾診斷市場，依最終用戶分類：

醫院和診所

診斷中心

居家護理

其他

  • 全球瘧疾診斷市場（按地區）：

北美洲

  • 美國
  • 墨西哥
  • 加拿大

歐洲

  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

亞太

  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 越南
  • 印尼
  • 緬甸

南美洲

  • 巴西
  • 哥倫比亞

中東和非洲

  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 埃及
  • 土耳其
  • 奈及利亞

競爭格局

公司簡介：全球瘧疾診斷市場主要公司的詳細分析。

可用的客製化：

根據給定的市場資料，TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自訂選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 考慮學習的年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球瘧疾診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按技術（分子診斷測試、快速診斷測試等）
    • 按最終使用者（醫院和診所、診斷中心、家庭護理等）
    • 按公司分類 (2022)
    • 按地區

第 6 章：北美瘧疾診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲瘧疾診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太地區瘧疾診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 越南
    • 印尼
    • 緬甸

第 9 章：南美洲瘧疾診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西展望
    • 哥倫比亞

第 10 章：中東和非洲瘧疾診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 埃及
    • 土耳其
    • 奈及利亞

第 11 章：市場動態

  • 動力
  • 挑戰

第 12 章：市場趨勢與發展

第13章：競爭格局

  • 訪問生物公司。
  • 雅培實驗室有限公司
  • 生物梅里埃公司
  • 阿爾托納診斷有限公司
  • Bio-Rad 實驗室有限公司
  • AdvaCare 製藥公司
  • 梅里爾生命科學列兵。有限公司
  • 阿維化學列兵。有限公司
  • 總理醫療公司列兵。有限公司
  • 愛科來有限公司

第 14 章：策略建議

簡介目錄
Product Code: 15000

Global malaria diagnostics market is anticipated to grow at a rapid pace in the forecast period, 2024-2028. This is attributed to the growing government fundings, increase in research and development activities (R&D), and rise in the number of people suffering from malaria across the world. Malaria is a life-threatening disease caused by the Plasmodium parasite, which is transmitted to humans through the bite of infected female Anopheles mosquitoes. It is a major public health concern, particularly in tropical and subtropical regions, where the conditions are favorable for mosquito breeding and malaria transmission. The Malaria diagnostic market plays a critical role as it ensures the early and accurate diagnosis of malaria. Also, the malaria diagnostics helps to ensure that the patient is receiving the appropriate treatment, preventing the overuse of drugs, providing important disease surveillance data, and reducing the spread of malaria.

Moreover, the global malaria diagnostics market is driven by the high prevalence of malaria in many regions of the world, particularly in sub-Saharan Africa, where malaria is a major public health concern. According to the World Health Organization (WHO), there were approximately 247 million cases of malaria reported worldwide in 2021, out of which 6,19,000 number of malaria deaths were estimated. The WHO African Region carries a disproportionately large amount of the worldwide malaria burden. In 2021, the Region witnessed 95% of malaria cases and 96% of malaria deaths.

In addition to these, there are several other factors which are supporting the growth of the global malaria diagnostics market such as increasing technological advancements, rising demand for diagnostic tools for malaria, increased awareness, and other government initiatives. For instance, in 2022, the Ministry of Health and Family Welfare of India launched a campaign named Jan Abhiyaans with log bhaagidari (people's participation) to enthuse and engage people and communities to ensure that their neighborhoods, premises, and homes for vector control and elimination.

High Prevalence of Malaria

Increasing prevalence of malaria across the world is influenced by various factors, including the presence of the mosquito vector that transmits the parasite, environmental factors that support mosquito breeding, access to effective malaria prevention and control measures, and the level of immunity to the disease in the population. Therefore, to reduce the prevalence of malaria, it is essential to implement effective malaria control strategies, such as early diagnosis and prompt treatment of malaria cases. The rowing prevalence of malaria can influence the demand and uptake of malaria diagnostic tests, which in turn, is expected to bolster the growth of the global malaria diagnostic market in the upcoming years. Rapid diagnostic tests (RDTs) and microscopy are commonly used to diagnose malaria, and accurate diagnosis is essential for effective disease management and control.

In areas with a high prevalence of malaria, the demand for these diagnostic tests can be particularly high, as healthcare providers strive to diagnose and treat as many cases as possible. Therefore, the growing occurrences of malaria across the globe are influencing the growth of the global malaria diagnostic market. According to the World Health Organization's 2021 report, approximately 50% of global malaria fatalities were attributed to just four African nations: Nigeria (31.3%), the Democratic Republic of the Congo (12.6%), United Republic of Tanzania (4.1%), and Niger (3.9%).

Increasing Investments and Technological Advancements

Global malaria diagnostic market has seen significant growth in recent years, and this can largely be attributed to the high prevalence of malaria in many countries. As the demand for malaria diagnostic tests increases, companies that produce these tests are expanding their operations and investing in research and development to improve the accuracy, sensitivity, and cost-effectiveness of their products. The high burden of malaria in many countries has driven the growth of the malaria diagnostic market. This high prevalence of malaria has led to a significant demand for malaria diagnostic tests, including rapid diagnostic tests (RDTs) and microscopy. In response to this demand, many companies have invested in the production and distribution of malaria diagnostic tests. These tests have become increasingly accessible in many countries, including those with a high burden of malaria. Companies producing malaria diagnostic tests have also focused on improving the accuracy, sensitivity, and cost-effectiveness of their products, making them more attractive to healthcare providers in resource-limited settings. Also, the growth of the global malaria diagnostic market has also been driven by technological advancements in diagnostic technologies. For example, there has been a significant shift towards the use of molecular diagnostic tests, such as polymerase chain reaction (PCR) tests, which can provide more accurate and sensitive results than traditional microscopy and RDTs. These new technologies are improving the accuracy of malaria diagnosis and helping to reduce the burden of the disease in many countries. In addition, another promising development in the field of malaria diagnostics is the use of artificial intelligence (AI) and machine learning (ML) algorithms to improve the accuracy and speed of malaria diagnosis. These tools can analyze large datasets of malaria cases to identify patterns and predict disease outbreaks, helping to inform public health interventions. Also, increase in research and development activities are done in order to develop new malaria diagnostic tools, such as biosensors and nanotechnology-based tests, which have the potential to improve the speed, sensitivity, and specificity of malaria diagnosis. These advancements as well as the introduction of novel malaria diagnostic techniques are expected to drive the growth of the global malaria diagnostic market in the forthcoming years.

Increasing Government Funding

Increasing government funding is another important factor driving the growth of the global malaria diagnostics market. Many governments, particularly in malaria-endemic countries, are investing in malaria control and elimination programs. This includes funding for the development and distribution of diagnostic tests, which has helped to drive growth in the malaria diagnostics market. Government funding has been instrumental in expanding access to malaria diagnostics, particularly in low-resource settings where malaria is most prevalent. Governments are often key stakeholders in the fight against malaria, and they play a critical role in financing and implementing malaria control programs. For example, the Global Fund to Fight AIDS, Tuberculosis and Malaria, which is a partnership between governments, civil society, and the private sector, has played a significant role in funding malaria control programs in many countries. The funding provided by governments has been used to develop new diagnostic technologies, improve the distribution of existing tests, and increase access to diagnostics in remote and low-resource settings. For example, some governments have invested in the development of new, more accurate and cost-effective rapid diagnostic tests (RDTs), which are particularly useful in resource-limited settings where traditional diagnostic methods may not be feasible. In addition, government funding has helped to support public health campaigns and education programs that emphasize the importance of malaria diagnosis and treatment. These programs can help to raise awareness about the benefits of early diagnosis and treatment, which can help to reduce the burden of malaria and improve health outcomes.

Market Segmentation:

Global malaria diagnostics market is segmented into technology, end user, company, and region. Based on technology, the global malaria diagnostics market is segmented into molecular diagnostics tests, rapid diagnostic tests, and others. Based on end user, the global Malaria diagnostics market is divided into hospitals & clinics, diagnostic centers, home care, and others. In terms of region, the Middle East & Africa dominated the global malaria diagnostics market on account of the increasing research & development activities along with an increase in the number of people suffering from malaria.

Market Players

Access Bio., Inc., Abbott Laboratories, Inc., bioMerieux SA, altona Diagnostics GmbH, Bio-Rad Laboratories, Inc., AdvaCare Pharma, Meril Life Sciences Pvt. Ltd., Advy Chemical Pvt. Ltd, Premier Medical Corporation Pvt. Ltd., and ARKRAY, Inc. are some of the major leading players of the global malaria diagnostics market.

Report Scope:

In this report, global malaria diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Malaria Diagnostics Market, By Technology:

Molecular Diagnostic Tests

Rapid Diagnostic Test

Others

  • Global Malaria Diagnostics Market, By End User:

Hospitals & Clinics

Diagnostic Centers

Home Care

Others

  • Global Malaria Diagnostics Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Europe

  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • India
  • Japan
  • South Korea
  • Australia
  • Vietnam
  • Indonesia
  • Myanmar

South America

  • Brazil
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Turkey
  • Nigeria

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global malaria diagnostics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Malaria Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology (Molecular Diagnostics Tests, Rapid Diagnostic Tests, and Others)
    • 5.2.2. By End User (Hospitals & Clinics, Diagnostic Centers, Home Care, and Others)
    • 5.2.3. By Company (2022)
    • 5.2.4. By Region

6. North America Malaria Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Malaria Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technology
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Malaria Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technology
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Malaria Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technology
        • 6.3.3.2.2. By End User

7. Europe Malaria Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Malaria Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By End User
    • 7.3.2. Germany Malaria Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Malaria Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Malaria Diagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technology
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Malaria Diagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technology
        • 7.3.5.2.2. By End User

8. Asia-Pacific Malaria Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. India Malaria Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By End User
    • 8.3.2. Japan Malaria Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By End User
    • 8.3.3. South Korea Malaria Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By End User
    • 8.3.4. Australia Malaria Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By End User
    • 8.3.5. Vietnam Malaria Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By End User
    • 8.3.6. Indonesia Malaria Diagnostics Market Outlook
      • 8.3.6.1. Market Size & Forecast
        • 8.3.6.1.1. By Value
      • 8.3.6.2. Market Share & Forecast
        • 8.3.6.2.1. By Technology
        • 8.3.6.2.2. By End User
    • 8.3.7. Myanmar Malaria Diagnostics Market Outlook
      • 8.3.7.1. Market Size & Forecast
        • 8.3.7.1.1. By Value
      • 8.3.7.2. Market Share & Forecast
        • 8.3.7.2.1. By Technology
        • 8.3.7.2.2. By End User

9. South America Malaria Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Malaria Diagnostics Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By End User
    • 9.3.2. Colombia Malaria Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By End User

10. Middle East & Africa Malaria Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Malaria Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By End User
    • 10.3.2. Saudi Arabia Malaria Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By End User
    • 10.3.3. UAE Malaria Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By End User
    • 10.3.4. Egypt Malaria Diagnostics Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Technology
        • 10.3.4.2.2. By End User
    • 10.3.5. Turkey Malaria Diagnostics Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Technology
        • 10.3.5.2.2. By End User
    • 10.3.6. Nigeria Malaria Diagnostics Market Outlook
      • 10.3.6.1. Market Size & Forecast
        • 10.3.6.1.1. By Value
      • 10.3.6.2. Market Share & Forecast
        • 10.3.6.2.1. By Technology
        • 10.3.6.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

  • 13.1. Access Bio., Inc.
  • 13.2. Abbott Laboratories, Inc.
  • 13.3. bioMerieux SA
  • 13.4. altona Diagnostics GmbH
  • 13.5. Bio-Rad Laboratories, Inc.
  • 13.6. AdvaCare Pharma
  • 13.7. Meril Life Sciences Pvt. Ltd.
  • 13.8. Advy Chemical Pvt. Ltd
  • 13.9. Premier Medical Corporation Pvt. Ltd.
  • 13.10. ARKRAY, Inc.

14. Strategic Recommendations